News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CardiAQ Valve Technologies (CVT) Offers New Hope for Cardiovascular Medicine


6/19/2012 7:40:17 AM

Nearly 50% of patients suffering from a diseased mitral heart valve with severe, symptomatic regurgitation are denied open-heart surgery because it is considered too risky; in the future, Transcatheter Mitral Valve Implantation (TMVI) may offer new hope for these patients.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES